Lymphoma, Large B-Cell, DiffuseAntineoplastic Combined Chemotherapy ProtocolsLymphoma, B-CellLymphomaChemotherapy, AdjuvantLymphoma, Non-HodgkinLymphoma, FollicularLymphoma, T-CellCyclophosphamideDoxorubicinCombined Modality TherapyTreatment OutcomeAntineoplastic AgentsCisplatinLymphoma, B-Cell, Marginal ZonePrognosisGerminal CenterLymphoma, T-Cell, PeripheralAntibodies, Monoclonal, Murine-DerivedProto-Oncogene Proteins c-bcl-6B-LymphocytesHodgkin DiseaseLymphoma, Large-Cell, ImmunoblasticDisease-Free SurvivalBurkitt LymphomaMediastinal NeoplasmsNeoadjuvant TherapySurvival AnalysisEtoposideNeoplasm StagingBreast NeoplasmsSurvival RateVincristineAntigens, CD79Drug Administration ScheduleMethotrexateLung NeoplasmsFatal OutcomeMyelin and Lymphocyte-Associated Proteolipid ProteinsImmunohistochemistryPrednisoneEpstein-Barr Virus InfectionsCarboplatinVinblastinePaclitaxelTranslocation, GeneticInduction ChemotherapyCell Line, TumorNeoplasm Recurrence, LocalTumor Markers, BiologicalAntigens, CD20BleomycinLymphoma, Mantle-CellDrug Resistance, NeoplasmIfosfamideTaxoidsNeoplasmsImmunophenotypingLymphoproliferative DisordersLymphoma, AIDS-RelatedAntimetabolites, AntineoplasticCytarabineDeoxycytidineOrganoplatinum CompoundsSalvage TherapyChemotherapy-Induced Febrile NeutropeniaFollow-Up StudiesTransplantation, AutologousLymphoma, T-Cell, CutaneousAntineoplastic Agents, AlkylatingAnthracyclinesGene Expression Regulation, NeoplasticImmunoglobulin Heavy ChainsCARD Signaling Adaptor ProteinsLymphoma, Large-Cell, AnaplasticChemotherapy, Cancer, Regional PerfusionTime FactorsCarcinoma, Non-Small-Cell LungHerpesvirus 4, HumanAntibodies, MonoclonalNeoplasm MetastasisB-Lymphocyte SubsetsTesticular NeoplasmsOvarian NeoplasmsProto-Oncogene Proteins c-bcl-2VomitingRadiotherapy, AdjuvantAdenocarcinomaAntineoplastic Agents, PhytogenicRadiotherapyNauseaNeutropeniaDacarbazineAntibiotics, AntineoplasticCarmustineKaplan-Meier EstimateProspective StudiesColorectal NeoplasmsClinical Trials as TopicRecurrence